Rare diseases
Investigational molecules
Locations
Long-Term Study of Ustekinumab for Patients with Crohn's Disease Who Previously Lost Response to Treatment
BelgiumStudy on Extended Access to Momelotinib for Patients with Myelofibrosis
BelgiumStudy of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy
BelgiumStudy Comparing Teclistamab with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma After 1-3 Prior Treatments
BelgiumTesting BI 1569912 for Major Depressive Disorder in Patients Using Antidepressants
BelgiumStudy of Lurbinectedin and Atezolizumab for Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer
BelgiumStudy of Batoclimab for Treating Patients with Active Thyroid Eye Disease
BelgiumStudy on NVD-003 Bone Graft for Treating Congenital Pseudarthrosis of the Tibia in Children
BelgiumStudy on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function
BelgiumStudy Comparing Risankizumab and Deucravacitinib for Adults with Moderate Plaque Psoriasis Eligible for Systemic Therapy
BelgiumStudy of ibrutinib and venetoclax combination therapy for patients with relapsed or refractory chronic lymphocytic leukemia who have adequate kidney function
BelgiumStudy Comparing Pirtobrutinib with Idelalisib and Rituximab or Bendamustine and Rituximab for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
